ArticleJournal of vascular surgery2025
Predictors of postoperative stroke after transfemoral carotid artery stenting.
Article in Journal of vascular surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
objectiveIn 2023, the Centers for Medicare and Medicaid Services expanded coverage for transfemoral carotid artery stenting (tfCAS) to include standard-risk patients. Given this shift, we sought to identify predictors of postoperative stroke in patients undergoing tfCAS.
methodsWe analyzed Vascular Quality Initiative data from 2011 to 2024, identifying tfCAS patients treated for atherosclerosis or restenosis. We excluded patients with interventions outside the internal carotid artery or bifurcation and procedures with concurrent intracranial treatment. We then stratified patients based on in-hospital postoperative stroke status. Baseline characteristics and outcomes were compared using χ
resultsIn our cohort of 35,346 tfCAS cases, 693 patients (2%) had an in-hospital post-procedure stroke. Patients who had a post-procedure stroke were older, more likely to be female, non-White, and had a higher overall comorbidity burden. After 10-fold cross-validation using the original logistic regression model, the factors most strongly associated with increased odds of stroke included uncontrolled hypertension (23% vs 14%; adjusted odds ratio [aOR], 2.66; 95% confidence interval [CI], 1.94-3.71; P < .001), emergent surgery (41% vs 32%; aOR, 2.39; 95% CI, 1.74-3.27; P < .001), severe distal tortuosity (13% vs 8%; aOR, 1.62; 95% CI, 1.25-2.27; P < .001), age greater than 75 years (41% vs 32%; aOR, 1.53; 95% CI, 1.23-1.92; P < .001), preoperative stroke (44% vs 29%; aOR, 1.57; 95% CI, 1.30-1.90; P < .001), prior carotid endarterectomy (14% vs 12%; aOR, 1.44; 95% CI, 1.14-1.81; P = .002), type III arch (7.1% vs 5.5%; aOR, 1.45; 95% CI, 1.02-2.03; P = .03), and circumferential or protruding calcification (3.3% vs 1.7%; aOR, 1.43; 95% CI, 1.04-1.93; P = .02). Dual antiplatelet therapy and having a high-volume physician or center were associated with lower odds of stroke. Based on variable importance, a simplified point system was developed to predict postoperative stroke (receiver operating characteristic area under the curve = 0.68).
conclusionsThe identified mediators of stroke risk after tfCAS offer the opportunity to improve patient selection. These data highlight the importance of managing modifiable factors preoperatively, such as hypertension and antiplatelet therapy. The timing of surgery also emerged as a strong predictor of stroke, suggesting the need for careful consideration of the need for emergent or urgent surgery. Anatomic considerations such as vessel tortuosity, arch type, and calcification should also prompt consideration for an alternate revascularization strategy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.